News & Insights
All
Corporate News
Insights
Corporate News
Danforth Health Acquires Ambit, Expanding its Integrated Capabilities Across the Rare and Specialty Disease Product Lifecycle
WALTHAM, Mass. – September 9, 2026 – Danforth Health, Inc. today announced the acquisition of Ambit RD, Inc., a technology-enabled…
Insights
AI Is About to Break the CRO Pricing Model
Explore how AI is changing CRO pricing models, clinical outsourcing, and contract negotiations—and what biotech sponsors need to know about…
Insights
A BCBS Massachusetts coverage change is hitting current renewals. Is your HR strategy ready?
BCBS Massachusetts is ending PPO and EPO plans for groups under 50. Learn what life science companies should consider for…
Insights
The GrowthCo Playbook: When to Hire, Partner, and Scale
Learn when early-stage biotech companies should hire, outsource, partner, and scale to protect cash runway, strengthen operations, and support sustainable…
Insights
Built to Transact: Aligning for IPO, M&A, or Strategic Deals in Biotech
Learn how biotech companies can strengthen transaction readiness for IPOs, M&A, licensing deals, and strategic partnerships after key clinical milestones.
Insights
Why HCP Engagement Can Make or Break an Ultra-Rare Disease Launch
Discover why HCP engagement is critical to ultra-rare disease launch success and how targeted physician support can improve adoption, access,…
Insights
Get Ahead of Risk: How Integrating Regulatory Early Drives Commercial Impact in Life Sciences
Discover how integrating regulatory early can reduce commercialization risk, align cross-functional teams, and drive stronger product impact in life sciences.
Insights
5 Steps Biopharma Companies Should Take Now to Prepare for MFN Drug Pricing
What is Most Favored Nation drug pricing? Explore how MFN policies can impact Medicare reimbursement, global pricing strategy, and pharma…
Insights
Life Sciences Hiring in 2026: How to Scale Talent While Reducing Cash Burn
Capital Is Unlocking. Hiring Is Returning. But Discipline Matters More Than Ever. After several years of constrained capital markets, life sciences market trends indicate that…
Contact Us
We want to hear from you
No matter where you are in your life sciences journey, we’re here to help. We welcome the opportunity to connect with prospective clients and other members of the life science ecosystem with whom we frequently work. Please complete the form to let us know about your specific needs and interests.